drugset / Trial / NCT02556580

Volume Kinetics for 20% Albumin in Different Clinical Situations

NCT02556580

Non-randomizedParallel-groupOpen-labelBasic science

Summary

The study aims to determine the degree of plasma volume expansion and the half-life of the plasma volume expansion when 3 mL/kg of hyperoncotic (20%) albumin if infused over 30 minutes in conscious healthy volunteers, in patients undergoing surgery under general anesthesia, and on the day after major surgery when the patient is in a post surgical inflammatory state. The study also examines the increase in the plasma colloid osmotic pressure as a result of this infusion and its possible influence on markers of kidney damage.

Timeline

Start
2016-02
Primary completion
2018-12-31
Completion
2019-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Albumin Protein / enzyme biologic 20 % Intravenous

Indications

No indication recorded.